Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors

Circulation Research

Volumn 83, Issue 12, 1998, Pages 1264-1270

  Caplice, Noel M ^a   Mueske, Cheryl S ^a   Kleppe, Laurel S ^a   Peterson, Timothy E ^a   Broze Jr , George J ^b   Simari, Robert D ^a,c  

^a MAYO CLINIC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Inhibitor; Regulation; Smooth muscle; Tissue factor

Indexed keywords

TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; GROWTH REGULATION; HUMAN; HUMAN CELL; INTIMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

EID: 0032576623     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.12.1264     Document Type: Article

References (25)

1. Rappaport S, Rao L. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 1992;12:1111-1121.
2. Wilcox J, Smith K, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
3. Fleck R, Rao L, Rappaport S, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;57:765-781.
4. Marmur J, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman M. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993;91:2253-2259.
5. Broze G, Girard T, Novotny W. Regulation of coagulation by multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539-7546.
6. Broze G Jr, Miletich J. Isolation of tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A. 1987;84:1886-1890.
7. Bajaj M, Kuppuswamy M, Saito H, Spitzer S, Bajaj S. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A. 1990;87:8869-8873.
8. Lindhout T, Blezer R, Schoen P, Nordfang O, Reutelingsperger C, Hemker H. Activation of factor X, and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood. 1992;79:2909-2916.
9. Werling RL, Zacharski W, Kisiel S, Bajaj S, Memoli V, Rousseau S. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost. 1993;69:366-369.
10. vanderLogt C, Dirven R, Reitsma P, Bertina R. Expression of tissue factor and tissue factor pathway inhibitors in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul Fibrinol. 1994;5:211-220.
11. Marmur J, Thiruvikraman S, Fyfe B, Guha A, Sharma S, Ambrose J, Fallon J, Nemerson Y, Taubman M. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
12. Ameri A, Kuppuswamy M, Basu S, Bajaj S. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood. 1992;79:3219-3226.
13. Bognacki J, Hammelburger J. Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor. Blood Coagul Fibrinol. 1995;6:S65-S72.
14. Sevinsky J, Rao L, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996; 133:293-304.
15. Stephan DS, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther. 1996;7:1803-1812.
16. Seedorf K. Intracellular signaling by growth factors. Metabolism. 1995; 44:24-32.
17. Drew A, Davenport P, Apostopoulos J, Tipping P. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 1997;77:291-298.
18. Lindahl A, Jacobsen P, Sandset P, Abildgaard U. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinol. 1991;2:713-721.
19. Rossi P, Karsenty G, Roberts A, Roche N, Sporn M, deCrombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor β. Cell. 1988; 52:405-414.
20. van der Logt C, Reitsma P, Bertina R. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation. Biochemistry. 1991;30:1571-1577.
21. Girard T, Eddy R, Wesselschmidt R, MacPhail L, Likert K, Byers M, Shows T, Broze GJ. Structure of the human lipoprotein-associated coagulation inhibitor gene. J Biol Chem. 1991;266:5036-5041.
22. Barrett T, Benditt E. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A. 1988;85:2870-2874,
23. Wilcox J, Smith K, Williams L, Schwartz S, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest. 1988;82:1134-1143.
24. Hughes S, Crossmann D, Hall P. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res. 1993;27:1214-1219.
25. Caplice N, Aroney C, Bett J, Cameron J, Campbell J, Hoffmann N, McEniery P, West M. Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture. J Am Coll Cardiol. 1997;29:1536-1541.